Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure | BioSpace Source Cluster: BioSpace Source Node: 3081002Time Stamp: Jan 22, 2024
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure | BioSpace Source Cluster: BioSpace Source Node: 2984476Time Stamp: Nov 28, 2023